Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3.75Price to Free Cash Flow
VS
Market
Sector
Industry
History
$ 5.47Close
$ 2.42 - $ 5.73 52-Week Range
Ticker Information
Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPUMA BIOTECHNOLOGY INC - Price to Free Cash Flow Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PBYI - P/FCF Historical data
| Date | Free Cash Flow | Market Capitalization | Price to Free Cash Flow |
|---|---|---|---|
| 6/30/2025 | $ 44.22M | $ 165.72M | 3.75 |
| 3/31/2025 | $ 31.17M | $ 152.39M | 4.89 |
| 12/31/2024 | $ 38.86M | $ 148.34M | 3.82 |
| 9/30/2024 | $ 33.68M | $ 148.74M | 4.42 |
| 6/30/2024 | $ 33.25M | $ 171.66M | 5.16 |
| 3/31/2024 | $ 35.47M | $ 239.26M | 6.75 |
| 12/31/2023 | $ 26.87M | $ 299.85M | 11.16 |
| 9/30/2023 | $ 24.14M | $ 118.45M | 4.91 |
| 6/30/2023 | $ 30.81M | $ 167.23M | 5.43 |
| 3/31/2023 | $ 13.71M | $ 121.91M | 8.89 |
Key Performance Insights, Last 5 Years
- PUMA BIOTECHNOLOGY INC's latest trailing twelve months (TTM) P/FCF stands at 44.05.
- Over the past 5 years, PUMA BIOTECHNOLOGY INC's average P/FCF has been 45.28.
- The median P/FCF for PUMA BIOTECHNOLOGY INC during this period was 6.09
- PUMA BIOTECHNOLOGY INC reached its highest P/FCF over the past 5 years at 565.39.
- The lowest P/FCF recorded by PUMA BIOTECHNOLOGY INC in the same timeframe 3.75
PUMA BIOTECHNOLOGY INC's P/FCF vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/FCF Benchmarks
Similar metrics to P/FCF:
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
Definition of Price to Free Cash Flow
[Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].Market Cap / FCF
(=) P/FCF P/FCF for PUMA BIOTECHNOLOGY INC is calculated as follows: Market Cap [ $ 336.79M ] / FCF [ $ 7.64M ]
(=) P/FCF [ 44.05 ] PBYI - Price to Free Cash Flow, Last 5 years
3.75
Minimum
Jun 30, 2025
565.39
Maximum
Dec 31, 2020
45.28
Average
6.09
Median
P/FCF Benchmark AnalysisMarket
The chart above depicts the distribution of P/FCF for companies in the Total Stock Market. The average P/FCF of the companies is 18.31 with a standard deviation of 12.92.
The following table provides additional summary stats:
P/FCF in the Market:
| filtered constituents | 2.23K |
|---|---|
| min | 0.06 |
| max | 60.45 |
| average | 18.31 |
| median | 14.73 |
| std | 12.92 |